Carna Biosciences, Inc. — Investor Relations & Filings
Carna Biosciences, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery and development of small molecule kinase inhibitors. The company focuses on creating therapies for diseases with significant unmet medical needs, particularly in oncology and autoimmune disorders. Carna Biosciences operates through two core segments: a drug discovery business that advances its proprietary pipeline of drug candidates, and a drug discovery support business. The support division provides the global research community with a comprehensive portfolio of products and services, including a wide array of kinase proteins, biochemical and cell-based screening, and profiling services to accelerate pharmaceutical research and development.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 四半期報告書－第20期第2四半期(令和4年4月1日－令和4年6月30日) | 2022-08-08 | Japanese | |
| 四半期報告書－第20期第1四半期(令和4年1月1日－令和4年3月31日) | 2022-05-11 | Japanese | |
| 内部統制報告書－第19期(令和3年1月1日－令和3年12月31日) | 2022-03-25 | Japanese | |
| 有価証券報告書－第19期(令和3年1月1日－令和3年12月31日) | 2022-03-25 | Japanese | |
| 確認書 | 2022-03-25 | Japanese | |
| 四半期報告書－第19期第3四半期(令和3年7月1日－令和3年9月30日) | 2021-11-09 | Japanese |
Browse filings by year
12 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2022
5 filings
| |||||
| 7595165 | 四半期報告書－第20期第2四半期(令和4年4月1日－令和4年6月30日) | 2022-08-08 | Japanese | ||
| 7610040 | 四半期報告書－第20期第1四半期(令和4年1月1日－令和4年3月31日) | 2022-05-11 | Japanese | ||
| 7613638 | 内部統制報告書－第19期(令和3年1月1日－令和3年12月31日) | 2022-03-25 | Japanese | ||
| 7613644 | 有価証券報告書－第19期(令和3年1月1日－令和3年12月31日) | 2022-03-25 | Japanese | ||
| 7613637 | 確認書 | 2022-03-25 | Japanese | ||
|
2021
6 filings
| |||||
| 7624380 | 四半期報告書－第19期第3四半期(令和3年7月1日－令和3年9月30日) | 2021-11-09 | Japanese | ||
| 7628799 | 四半期報告書－第19期第2四半期(令和3年4月1日－令和3年6月30日) | 2021-08-10 | Japanese | ||
| 7672367 | 四半期報告書－第19期第1四半期(令和3年1月1日－令和3年3月31日) | 2021-05-11 | Japanese | ||
| 7673893 | 内部統制報告書－第18期(令和2年1月1日－令和2年12月31日) | 2021-03-26 | Japanese | ||
| 7673892 | 確認書 | 2021-03-26 | Japanese | ||
| 7673894 | 有価証券報告書－第18期(令和2年1月1日－令和2年12月31日) | 2021-03-26 | Japanese | ||
|
2020
4 filings
| |||||
| 7681960 | 四半期報告書－第18期第3四半期(令和2年7月1日－令和2年9月30日) | 2020-11-10 | Japanese | ||
| 7685894 | 四半期報告書－第18期第2四半期(令和2年4月1日－令和2年6月30日) | 2020-08-11 | Japanese | ||
| 7691000 | 四半期報告書－第18期第1四半期(令和2年1月1日－令和2年3月31日) | 2020-05-13 | Japanese | ||
| 7691700 | 有価証券報告書－第17期(平成31年1月1日－令和1年12月31日) | 2020-03-27 | Japanese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Carna Biosciences, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/11390/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=11390 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=11390 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=11390 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 11390}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Carna Biosciences, Inc. (id: 11390)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.